Redwood AI Corp. (CVE:AIRX) | Finanzwire

Basculer en Français

10238	Companies
211356	Keywords
141292	Articles
111971	Press releases

Home
Companies
Redwood AI Corp.

BRIEF

published on 04/18/2026 at 00:05, 12 hours 32 minutes ago

Redwood AI Partners with Aidos Innovations to Combat Fentanyl Crisis in B.C.

Public Safety Redwood AI Aidos Innovations Fentanyl Crisis Track And Trace
PRESS RELEASE

published on 04/18/2026 at 00:00, 12 hours 37 minutes ago

Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Redwood & Aidos launch 'Track and Trace' AI initiative to combat opioid crisis. Analytical platform aims to enhance public safety and health response

Opioid Crisis Redwood AI AI Initiative Aidos Innovations Track And Trace
BRIEF

published on 04/10/2026 at 00:05, 8 days 12 hours ago

Redwood AI Unveils Enhanced Reactosphere Platform for Secure Cloud Deployment

Redwood AI Corp Reactosphere Platform Security Enhancements Cloud Deployment AI-driven Synthesis
PRESS RELEASE

published on 04/10/2026 at 00:00, 8 days 12 hours ago

Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Redwood AI Corp. announces cloud deployment of Reactosphere software, enhancing platform's security, stability, and scalability for defence-related industries and high-security environments

Redwood AI Corp. Defence Industry Security Enhancements Cloud Deployment Reactosphere Software
BRIEF

published on 04/02/2026 at 00:05, 16 days 12 hours ago

Redwood AI and UBC Collaborate on Alzheimer's Drug Research

AI-driven Research Redwood AI Corp Brent Page Lab Alzheimer's Drug Discovery NUDT5 Inhibitors
PRESS RELEASE

published on 04/02/2026 at 00:00, 16 days 12 hours ago

Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Redwood AI Corp. partners with Brent Page Lab at UBC for research on Alzheimer's disease drugs using AI-driven computational platform and medicinal chemistry expertise

Redwood AI Corp. Brent Page Lab Alzheimer's Disease Drugs AI-driven Computational Platform Medicinal Chemistry
BRIEF

published on 03/24/2026 at 23:05, 24 days 13 hours ago

Redwood AI to Showcase Technology at BIO-Europe Spring 2026

BIO-Europe Spring Biotech Conference Redwood AI Chemical Synthesis Reactosphere Platform
PRESS RELEASE

published on 03/24/2026 at 23:00, 24 days 13 hours ago

Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Redwood AI Corp. selected to present at BIO-Europe Spring 2026, showcasing AI-driven chemical synthesis platform, Reactosphere, for safer and efficient decision-making in chemistry. CEO Louis Dron to present on March 25, 2026, in Lisbon, Portugal

AI-driven Redwood AI Corp. BIO-Europe Spring 2026 Reactosphere Louis Dron
BRIEF

published on 03/17/2026 at 23:15, 1 month ago

Redwood AI CEO Discusses AI Chemistry Platform on Conversations That Matter

Pharmaceutical Industry Defense Applications AI Chemistry Platform Redwood AI Corp Interview Feature
PRESS RELEASE

published on 03/17/2026 at 23:10, 1 month ago

Redwood AI CEO Louis Dron Featured on Conversations That Matter to Discuss AI Chemistry Platform and Broader Applications
Redwood AI Corp. CEO, Louis Dron, featured in an exclusive interview on Conversations That Matter, discussing the company's AI platform for pharmaceutical industry and broader chemistry-driven applications

Pharmaceutical Industry Redwood AI Corp. Louis Dron Conversations That Matter Chemistry AI Platform

Accesswire

Published on 04/18/2026 at 04:00, 8 hours 37 minutes ago

Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 10 hours 37 minutes ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 11 hours 2 minutes ago

Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 11 hours 37 minutes ago

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 12 hours 37 minutes ago

Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia

View all ACCESSWIRE

EQS Group

Published on 04/18/2026 at 00:05, 12 hours 32 minutes ago

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 20:33, 16 hours 3 minutes ago

LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:35, 17 hours 2 minutes ago

Stabilisation Notice
Published on 04/17/2026 at 19:30, 17 hours 6 minutes ago

KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 19:29, 17 hours 7 minutes ago

EQS-Adhoc: KAP AG: KAP AG: REFINANCING CONCEPT AGREED; TERM OF EXISTING SYNDICATED LOAN EXTENDED BY THREE YEARS

Les Echos

Published on 04/17/2026 at 19:00, 17 hours 37 minutes ago

Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 18 hours 52 minutes ago

Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 15:26, 21 hours 11 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of March 31, 2026
Published on 04/17/2026 at 09:10, 1 day 3 hours ago

Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 1 day 18 hours ago

Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026

View all LES ECHOS COMFI WIRE